Rare Diseases

Blood Cancer Awareness Month 2026 | Advancing Blood Cancer Research Through Synthetic Data

01 September 2026

During Blood Cancer Awareness Month, SYNTHIA joins the global community in raising awareness of blood cancers and highlighting the importance of continued research and innovation to improve treatment and outcomes for patients.

DLBCL, Multiple Myeloma, Patients, Precision Medicine, Rare Diseases, Synthetic Data, Technology

SYNTHIA Insight 8: Testing Synthetic Data Where It Matters Most: From Rare Disease Data to Real-World Clinical Research

20 June 2026

Insight featuring Mattia Delleani Founding Engineer at TRAIN.

AI, Clinical Research, Data Validation, Hematology, Privacy, Rare Diseases, Synthetic Data